This grant to Population Services International (PSI) will support the inclusion of medication abortion (MA) on the list of available reproductive health products marketed through a new regional social enterprise for Eastern Africa. PSI is developing a sustainable enterprise to market and distribute a selection of health products in Kenya, Tanzania, Uganda and Ethiopia. This grant will support market introduction of medication abortion in that enterprise, including assessment of pharmacy and health care worker barriers to MA, information needs of users, and market dynamics associated with MA products that impact financial sustainability.
About the Grantee
1120 Nineteenth Street, N.W., Suite 600, Washington, DC, 20036-3605, United States
Grants to this Grantee
for support of self-care for sexual and reproductive health
This grant to Population Services International will support the Self-Care Trailblazer Group to expand its field-building activities to promote user-controlled sexual and reproductive health. Co-funded with the Children’s Investment Fund Foundation, this project aims to bringtogether self-care stakeholders and advocates in a community of practice to consolidate concepts and communicate around key events in 2020, build the evidence on self-care, and advocate for the adoption of recent World Health Organization guidelines on user-controlled health care. This second grant will focus on deeper country-level engagement in promising countries as well as an intention to shift the leadership of the secretariat to a focus country by the end of this grant cycle.
for support of Population Services International's Francophone West Africa program
This project seeks to reduce maternal mortality due to unsafe abortion in Francophone West Africa. Population Services International will use insights about women’s preferences to increase reproductive health options and use commercial marketing techniques to promote new products in several countries in West Africa. It will also test innovative models that require less infrastructure to distribute reproductive health products and look for opportunities to provide alternatives for women who otherwise would seek a clandestine abortion.